<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kuhlmann H</submitter><funding>Stiftung Universitätsmedizin Essen</funding><pagination>1167</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10604239</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(10)</volume><pubmed_abstract>Hyperspectral imaging (HSI) is a non-invasive technology that provides information on biochemical tissue properties, including skin oxygenation and perfusion quality. Microcirculatory alterations are associated with organ dysfunction in septic COVID-19 patients. This prospective observational study investigated associations between skin HSI and organ dysfunction severity in critically ill COVID-19 patients. During the first seven days in the ICU, palmar HSI measurements were carried out with the TIVITA&lt;sup>®&lt;/sup> tissue system. We report data from 52 critically ill COVID-19 patients, of whom 40 required extracorporeal membrane oxygenation (ECMO). HSI parameters for superficial tissue oxygenation (StO&lt;sub>2&lt;/sub>) and oxygenation and perfusion quality (NPI) were persistently decreased. Hem</pubmed_abstract><journal>Bioengineering (Basel, Switzerland)</journal><pubmed_title>Bedside Hyperspectral Imaging and Organ Dysfunction Severity in Critically Ill COVID-19 Patients-A Prospective, Monocentric Observational Study.</pubmed_title><pmcid>PMC10604239</pmcid><funding_grant_id>20204699120</funding_grant_id><pubmed_authors>Garczarek L</pubmed_authors><pubmed_authors>Kunne D</pubmed_authors><pubmed_authors>Brenner T</pubmed_authors><pubmed_authors>Schmidt B</pubmed_authors><pubmed_authors>Arends S</pubmed_authors><pubmed_authors>Pattberg K</pubmed_authors><pubmed_authors>Frank M</pubmed_authors><pubmed_authors>Herbstreit F</pubmed_authors><pubmed_authors>Kuhlmann H</pubmed_authors><pubmed_authors>Espeter F</pubmed_authors><pubmed_authors>Skarabis A</pubmed_authors><pubmed_authors>Schmidt K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Bedside Hyperspectral Imaging and Organ Dysfunction Severity in Critically Ill COVID-19 Patients-A Prospective, Monocentric Observational Study.</name><description>Hyperspectral imaging (HSI) is a non-invasive technology that provides information on biochemical tissue properties, including skin oxygenation and perfusion quality. Microcirculatory alterations are associated with organ dysfunction in septic COVID-19 patients. This prospective observational study investigated associations between skin HSI and organ dysfunction severity in critically ill COVID-19 patients. During the first seven days in the ICU, palmar HSI measurements were carried out with the TIVITA&lt;sup>®&lt;/sup> tissue system. We report data from 52 critically ill COVID-19 patients, of whom 40 required extracorporeal membrane oxygenation (ECMO). HSI parameters for superficial tissue oxygenation (StO&lt;sub>2&lt;/sub>) and oxygenation and perfusion quality (NPI) were persistently decreased. Hem</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Oct</publication><modification>2025-04-04T10:06:47.412Z</modification><creation>2025-04-04T10:06:47.412Z</creation></dates><accession>S-EPMC10604239</accession><cross_references><pubmed>37892897</pubmed><doi>10.3390/bioengineering10101167</doi></cross_references></HashMap>